# KORU Medical Systems, Inc.: filings

KRMD · Nasdaq · CIK 704440 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/krmd.md) · [Financials](/companies/krmd/financials.md) · [Filings](/companies/krmd/filings.md) · [Insiders](/companies/krmd/insiders.md)

## Reports and events: 231 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 454, 8-K 128, 10-Q 53, 3 30, 4/A 30, 5 18, 10-K 17, 424B3 17, SC 13D/A 12, SC 13G/A 12, DEF 14A 10, S-8 7, 144 6, UPLOAD 6, PRE 14A 5, SC 13G 5, SCHEDULE 13G/A 5, 10-Q/A 4, CORRESP 4, EFFECT 4, S-8 POS 4, 3/A 3, DEFA14A 3, 424B5 2, 5/A 2, S-3 2, SC 13D 2, SCHEDULE 13D/A 2, SCHEDULE 13G 2, 10-KT 1, 8-A12B 1, 8-A12B/A 1, 8-K/A 1, CERT 1, POS AM 1, S-1 1, S-1/A 1, S-3/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-14 | 20:01 ET | [8-K](/filings/0001161697-26-000200.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001161697-26-000200 |
| 2026-08-05 | 20:08 ET | [10-Q](/filings/0001161697-26-000189.md) | Quarterly report, period 2026-06-30 | 0001161697-26-000189 |
| 2026-08-05 | 20:04 ET | [8-K](/filings/0001161697-26-000188.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-26-000188 |
| 2026-06-30 | 20:57 ET | [8-K](/filings/0001161697-26-000139.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001161697-26-000139 |
| 2026-05-21 | 20:11 ET | [8-K](/filings/0001161697-26-000128.md) | 5.07 Shareholder vote results | 0001161697-26-000128 |
| 2026-05-06 | 20:04 ET | [10-Q](/filings/0001161697-26-000108.md) | Quarterly report, period 2026-03-31 | 0001161697-26-000108 |
| 2026-05-06 | 20:02 ET | [8-K](/filings/0001161697-26-000107.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-26-000107 |
| 2026-04-09 | 20:03 ET | [DEF 14A](/filings/0001161697-26-000091.md) | Proxy statement, period 2025-12-31 | 0001161697-26-000091 |
| 2026-04-03 | 20:00 ET | [8-K](/filings/0001161697-26-000086.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001161697-26-000086 |
| 2026-03-16 | 01:44 ET | [8-K](/filings/0001161697-26-000055.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001161697-26-000055 |
| 2026-03-12 | 20:09 ET | [10-K](/filings/0001161697-26-000052.md) | Annual report, period 2025-12-31 | 0001161697-26-000052 |
| 2026-03-12 | 20:05 ET | [8-K](/filings/0001161697-26-000051.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-26-000051 |
| 2026-02-13 | 21:56 ET | [SCHEDULE 13D/A](/filings/0001161697-26-000042.md) | Ownership report, active investor, amended | 0001161697-26-000042 |
| 2026-02-11 | 02:08 ET | [8-K](/filings/0001161697-26-000038.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001161697-26-000038 |
| 2026-01-12 | 15:25 ET | [8-K](/filings/0001161697-26-000027.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-26-000027 |
| 2025-11-25 | 21:11 ET | [8-K](/filings/0001161697-25-000426.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001161697-25-000426 |
| 2025-11-12 | 21:07 ET | [10-Q](/filings/0001161697-25-000372.md) | Quarterly report, period 2025-09-30 | 0001161697-25-000372 |
| 2025-11-12 | 21:03 ET | [8-K](/filings/0001161697-25-000371.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-25-000371 |
| 2025-08-06 | 20:11 ET | [10-Q](/filings/0001161697-25-000217.md) | Quarterly report, period 2025-06-30 | 0001161697-25-000217 |
| 2025-08-06 | 20:08 ET | [8-K](/filings/0001161697-25-000216.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-25-000216 |
| 2025-05-15 | 20:56 ET | [8-K](/filings/0001161697-25-000173.md) | 5.07 Shareholder vote results | 0001161697-25-000173 |
| 2025-05-07 | 20:22 ET | [10-Q](/filings/0001161697-25-000169.md) | Quarterly report, period 2025-03-31 | 0001161697-25-000169 |
| 2025-05-07 | 20:21 ET | [8-K](/filings/0001161697-25-000168.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-25-000168 |
| 2025-04-07 | 20:06 ET | [8-K](/filings/0001161697-25-000142.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001161697-25-000142 |
| 2025-04-04 | 20:03 ET | [8-K](/filings/0001161697-25-000140.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001161697-25-000140 |
| 2025-04-04 | 20:02 ET | [DEF 14A](/filings/0001161697-25-000139.md) | Proxy statement, period 2024-12-31 | 0001161697-25-000139 |
| 2025-03-12 | 20:28 ET | [10-K](/filings/0001161697-25-000103.md) | Annual report, period 2024-12-31 | 0001161697-25-000103 |
| 2025-03-12 | 20:18 ET | [8-K](/filings/0001161697-25-000099.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-25-000099 |
| 2025-01-21 | 01:20 ET | [SCHEDULE 13D/A](/filings/0001161697-25-000060.md) | Ownership report, active investor, amended | 0001161697-25-000060 |
| 2025-01-13 | 14:21 ET | [8-K](/filings/0001161697-25-000050.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001161697-25-000050 |
| 2024-11-13 | 21:02 ET | [10-Q](/filings/0001161697-24-000441.md) | Quarterly report, period 2024-09-30 | 0001161697-24-000441 |
| 2024-11-13 | 21:01 ET | [8-K](/filings/0001161697-24-000440.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-24-000440 |
| 2024-08-21 | 21:25 ET | [8-K](/filings/0001161697-24-000365.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001161697-24-000365 |
| 2024-08-07 | 20:02 ET | [8-K](/filings/0001161697-24-000335.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-24-000335 |
| 2024-08-07 | 20:01 ET | [10-Q](/filings/0001161697-24-000334.md) | Quarterly report, period 2024-06-30 | 0001161697-24-000334 |
| 2024-07-24 | 20:25 ET | [8-K](/filings/0001161697-24-000314.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001161697-24-000314 |
| 2024-06-03 | 21:19 ET | [8-K](/filings/0001161697-24-000250.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001161697-24-000250 |
| 2024-05-14 | 21:06 ET | [8-K](/filings/0001161697-24-000230.md) | 5.07 Shareholder vote results | 0001161697-24-000230 |
| 2024-05-01 | 20:03 ET | [10-Q](/filings/0001161697-24-000226.md) | Quarterly report, period 2024-03-31 | 0001161697-24-000226 |
| 2024-05-01 | 20:01 ET | [8-K](/filings/0001161697-24-000225.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-24-000225 |
| 2024-04-11 | 20:44 ET | [8-K](/filings/0001161697-24-000196.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001161697-24-000196 |
| 2024-03-28 | 20:30 ET | [DEF 14A](/filings/0001161697-24-000162.md) | Proxy statement, period 2023-12-31 | 0001161697-24-000162 |
| 2024-03-13 | 20:19 ET | [8-K](/filings/0001161697-24-000140.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001161697-24-000140 |
| 2024-03-13 | 20:18 ET | [10-K](/filings/0001161697-24-000139.md) | Annual report, period 2023-12-31 | 0001161697-24-000139 |
| 2024-01-02 | 23:20 ET | [SC 13D/A](/filings/0001193125-23-306041.md) | Ownership report, active investor, amended | 0001193125-23-306041 |
| 2023-11-08 | 21:06 ET | [10-Q](/filings/0001161697-23-000568.md) | Quarterly report, period 2023-09-30 | 0001161697-23-000568 |
| 2023-11-08 | 21:05 ET | [8-K](/filings/0001161697-23-000567.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001161697-23-000567 |
| 2023-10-04 | 20:21 ET | [8-K](/filings/0001161697-23-000522.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001161697-23-000522 |
| 2023-08-09 | 20:20 ET | [10-Q](/filings/0001161697-23-000443.md) | Quarterly report, period 2023-06-30 | 0001161697-23-000443 |
| 2023-08-09 | 20:17 ET | [8-K](/filings/0001161697-23-000441.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-23-000441 |

Page 1 of 5. [Older](/companies/krmd/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:56 ET. No prices; not investment advice.